Yuhui Sun | Gene Therapy | Excellence in Research

Prof. Dr. Yuhui Sun | Gene Therapy | Excellence in Research

Huazhong University of Science and Technology | China

Prof. Dr. Yuhui Sun is a Professor at Huazhong University of Science and Technology, China. He received his Ph.D. from Shanghai Jiao Tong University and conducted postdoctoral research at the University of Cambridge in Professor Peter F. Leadlay’s group. He served as a Professor at Wuhan University before joining HUST. His research focuses on microbial natural product discovery, biosynthesis, and the development of advanced genetic and genome-editing tools, particularly CRISPR-Cas9–based base editors. Professor Sun has led eight major national and provincial research projects, published 69 SCI-indexed papers with an H-index of 25 and over 1,900 citations, authored a Springer Nature book chapter, and holds nine international and Chinese patents. He has extensive industry collaboration experience, serves on multiple international editorial boards, and is a Fellow of the Royal Society of Chemistry (UK). Internationally recognized for elucidating complex biosynthetic mechanisms and creating hybrid microbial medicines, he has also developed widely adopted genome-editing technologies shared with over 80 research groups worldwide.

Citation Metrics (Scopus)

2400
1800
1200
  600
  0

Citations
2,070

Documents
72

h-index
27

Citations

Documents

h-index


View Scopus Profile
View Orcid Profile

Featured Publications

Changcai Teng | Molecular genetics | Research Excellence Award

Prof. Dr. Changcai Teng | Molecular genetics | Research Excellence Award

Academy of Agriculture and Forestry, Qinghai university | China

Prof. Dr. Changcai Teng, born on 27 May 1982, is a Chinese crop genetics and breeding specialist currently serving as a Faba Bean Breeder at the Qinghai Academy of Agriculture and Forestry Science and Qinghai University’s Academy of Agriculture and Forestry. He holds a PhD (2018) and MSc (2009) in crop genetics and breeding, as well as a postgraduate qualification in forestry science (2004), all from Qinghai University in Xining, China. With professional experience spanning roles at the Agricultural Technology Promotion Center in Gonghe County and the Sino-Canada joint venture Jason Group Corporation Luyuan Ecology Co., Ltd, his research has focused on the genetics and breeding of Spring Brassica napus, potato, and faba bean. Proficient in Chinese and English, he is based in Xining, Qinghai Province.

Profiles: Scopus 

Featured Publications

"Genome-wide identification of the MADS-box gene family and their role in the formation of faba bean (Vicia faba L.) growth habits", Prof. Dr. Changcai Teng., 2025

Nasrin Samadyar | Cancer Genetics | Research Excellence Award

Dr. Nasrin Samadyar | Cancer Genetics | Research Excellence Award

Kermanshah University of Technology, Kermanshah | Iran

Dr. Nasrin Samadyar, born on 17 June 1989 in Karaj, Alborz Province, Iran, is an Iranian applied mathematician specializing in numerical analysis, stochastic differential equations, and meshfree computational methods. She earned her BSc in Applied Mathematics from Kharazmi University, followed by an MSc from Amirkabir University of Technology and a PhD in Applied Mathematics (Numerical Analysis) from Malayer University, where her doctoral research focused on meshfree radial basis function methods for solving stochastic integral equations. She later completed a postdoctoral fellowship in Mathematics at Alzahra University, concentrating on numerical solutions of stochastic differential and partial differential equations. A dedicated educator, she has taught courses such as Numerical Analysis, Linear Optimization, Calculus, and Numerical Linear Algebra. Samadyar has authored numerous high-impact journal publications spanning stochastic integral equations, fractional models, operational matrix methods, wavelet techniques, and meshless approaches, contributing significantly to computational mathematics. She also serves as a reviewer for leading international journals, including the International Journal of Biomathematics, Journal of Computational and Applied Mathematics, Applied Mathematics and Computation, and Soft Computing. A member of Iran's National Elites Foundation, she has supervised graduate research on numerical and stochastic equation-solving techniques and participated in advanced mathematical projects, including implicit meshless methods for fractional stochastic Tricomi-type equations. Proficient in MATLAB, MAPLE, MATHEMATICA, LaTeX, and C++, Samadyar continues to advance research in applied and stochastic mathematics through rigorous analysis, innovative numerical schemes, and interdisciplinary applications.

Profiles: ScopusGoogle Scholar

Featured Publications

"A new scheme for solving nonlinear Stratonovich Volterra integral equations via Bernoulli’s approximation, Appl", F. Mirzaee, N. Samadyar, S.F. Hosseini., 2025

"Euler polynomial solutions of nonlinear stochastic Ito-Volterra integral equations, J. Comput. Appl",F. Mirzaee, N. Samadyar, S.F. Hosseini., 2025

"Application of orthonormal Bernstein polynomials to construct a efficient scheme for solving fractional stochastic integro-differential equation, Optik Int. J. Light Electron Opt", F. Mirzaee, N. Samadyar., 2025

"Numerical solution of nonlinear stochastic Ito-Volterra integral equations driven by fractional Brownian motion, Math. Meth. Appl",F. Mirzaee, N. Samadyar., 2025

Xinghua Pan | Next-Generation Sequencing | Research Excellence Award

Prof. Xinghua Pan | Next-Generation Sequencing | Research Excellence Award

Macau University of Science and Technology | China

Prof. Xinghua (Victor) Pan, PhD, MD, is a distinguished scholar in single-cell technology, genome medicine, cancer biology, regenerative medicine, and multi-omics bioinformatics, currently serving as a Professor at the Precision Regenerative Medicine Research Centre (PRMRC) in the Medical Science Division of Macau University of Science and Technology (MUST), with a secondary affiliation at the State Key Laboratory of Quality Research in Chinese Medicine. A doctoral supervisor in Biomedical Science and Pharmacy programs at MUST, Dr. Pan previously served as Chairman and Professor of Biochemistry and Molecular Biology at Southern Medical University (SMU), where he founded and led the Guangdong Provincial Key Laboratory of Single Cell Technology and Application and held multiple adjunct roles across major hospitals, universities, and national laboratories. With a career spanning Yale University—where he advanced from Associate Research Scientist to Research Scientist and PI-and leadership positions in molecular genomics companies, Dr. Pan brings decades of expertise shaped by rigorous training at Southern Medical University, Fudan University, CAMS & PUMC, and Yale University, complemented by international fellowships at Peking University, Melbourne University, the Ludwig Institute, and Cold Spring Harbor Laboratory. Renowned for pioneering single-cell sequencing innovations-including multiomics, copy-number, methylome, transcriptome, telomere, and multiplexing technologies-he has applied these breakthroughs to major biomedical challenges across cancer, stem cells, organoids, aging, infectious diseases, immunology, brain disorders, and precision medicine. Dr. Pan has authored over 160 publications in high-impact journals such as Nature, PNAS, Advanced Science, Nucleic Acids Research, and Nature Communications, accumulating more than 8,500 citations and an H-index of 40, alongside 15 issued patents in the U.S. and China. His work has been supported by national and international foundations including NSFC, NIH, NSF, MOST, and leading provincial and municipal programs. A dedicated educator who has trained over 60 researchers and taught nearly 10,000 students, he also serves as an Associate Editor of Precision Clinical Medicine and Monocytomics, reviewer for more than 30 top journals, and evaluator for major grant agencies and academic degree committees. As an organizer and keynote speaker at over 100 global conferences, including co-chairing the International Conference on Single Cell and Spatial Omics (TICSSO), Dr. Pan has also held leadership roles in multiple scientific societies and earned numerous accolades such as UICC and CSHL Scholarships, PolyGenomics Fellowship, VEBLEO Fellow, Nanjing Leading Talent, Guangzhou High-Level Talent, Ganpo Distinguished Professor, and the CastUSA Single Cell Genomics Pioneer Award, solidifying his global influence in single-cell biology and precision regenerative medicine.

Profiles: Scopus | Orcid

Featured Publications

"A medium throughput approach for single cell copy number variation sequencing towards efficient application in clinics", Guanchuan Lin; Caiming Chen; Mengchang Xu; Bin Peng; Zhanying Dong; Xuewen Zhou; Jinyu Gao; Jie Yu; Bei Jia; Chen Luo et al., 2025

"Causal effects of immune cell phenotypes on the risk of autoimmune liver diseases: a bidirectional two-sample Mendelian randomization study",Hongjie Zou; Xinghe Liang; Mengqi Luo; Xinghua Pan; De-Ke Jiang., 2025

"Dynamic heterogeneity towards drug resistance in AML cells is primarily driven by epigenomic mechanism unveiled by multi-omics analysis", Yulong Zhang; Yanfang Lu; Liyao Mai; Zebin Wen; Min Dai; Siwen Xu; Xianwei Lin; Yongjian Luo; Yinbin Qiu; Yuting Chen et al., 2025

"Transcriptomics-driven exploration of genetic variation and peptide discovery in the sea anemones Anthopleura midori and Actinia equina",Han Zhang; Xinghua Pan; Chen Weigang., 2025

Fang Wang | Respiratory Medicine | Best Researcher Award

Fang Wang | Respiratory Medicine | Best Researcher Award

Jilin University | China

Author Profile

Orcid ID

EARLY ACADEMIC PURSUITS

Professor Fang Wang’s academic journey is rooted in a strong foundation of biomedical sciences. He demonstrated a commitment to medical research early in his career, focusing on genetics and respiratory medicine. With a solid academic background and advanced education in the medical sciences, he rose through the ranks in academia to eventually become a leading figure in his field. His early interest in Mendelian genetics and inheritance patterns, combined with a scientific curiosity about regional diseases, laid the groundwork for his lifelong research pursuits.

PROFESSIONAL ENDEAVORS

Professor Fang Wang currently holds several prestigious leadership roles at Jilin University, where he serves as the Dean of the School of Basic Medicine, the Dean of the Institute of Translational Medicine, and the Dean of the Ginseng Research Institute. In addition to these leadership positions, he is also a doctoral supervisor, mentoring the next generation of medical researchers. His distinguished service has been recognized by the State Council, where he is a recipient of the Special Government Allowance, a significant national honor. During the COVID-19 pandemic, his dedication to public health and medical innovation earned him recognition as an advanced individual in the national science and technology system.

CONTRIBUTIONS AND RESEARCH FOCUS ON RESPIRATORY MEDICINE

Professor Wang’s research has primarily focused on the pathogenesis of airway diseases in cold regions and translational medicine. His work is known for bridging basic scientific findings with clinical applications, particularly in the field of respiratory medicine. A significant part of his research explores genetic and environmental interactions in respiratory disorders, especially in populations exposed to cold climates. His studies often incorporate innovative approaches in functional materials, redox biology, and drug delivery systems, contributing to both academic and clinical advancements.

IMPACT AND INFLUENCE

Over the years, Professor Wang’s work has had a substantial impact on both national and international levels. He has published more than 60 SCI-indexed articles in prominent journals such as the European Respiratory Journal, Advanced Functional Materials, Redox Biology, Respiratory Medicine, and the Journal of Controlled Release. These publications are widely cited and have influenced ongoing research in respiratory genetics, cold-region pathophysiology, and biomedical interventions. His achievements have earned him more than 10 prestigious awards, including the Chinese Medical Science and Technology Award, the Jilin Provincial Science and Technology Award, and the Jilin Provincial Science and Technology Achievement Transformation Contribution Award.

ACADEMIC CITES

Professor Fang Wang’s academic output is both prolific and impactful. His more than 60 publications in high-impact journals are frequently cited by researchers in genetics, respiratory diseases, and translational medicine. His citation record reflects the relevance and scientific merit of his research. Furthermore, his seven invention patents highlight his contributions to medical innovation and the practical application of scientific knowledge in healthcare.

LEGACY AND FUTURE CONTRIBUTIONS

Professor Wang’s legacy lies in his dual contributions to academic excellence and public health innovation. As a mentor, leader, and researcher, he has shaped institutional development at Jilin University and elevated the standard of translational research in China. Looking forward, he is poised to further contribute to global respiratory medicine, particularly through interdisciplinary research combining genetics, environmental science, and clinical therapeutics. His ongoing efforts in the transformation of scientific achievements into practical healthcare solutions are expected to leave a lasting mark on the future of medicine.

NOTABLE PUBLICATIONS

"Correction: Tang et al. Integrated Multi-Omics Analysis Reveals Mountain-Cultivated Ginseng Ameliorates Cold-Stimulated Steroid-Resistant Asthma by Regulating Interactions among Microbiota, Genes, and Metabolites.

  • Author: Daohao Tang; Chao Wang; Hanlin Liu; Junzhe Wu; Luying Tan; Sihan Liu; Haoming Lv; Cuizhu Wang; Fang Wang; Jinping Liu
  • Journal: International Journal of Molecular Sciences
  • Year: 2024

"Mechanisms Underlying the Therapeutic Effects of JianPiYiFei II Granules in Treating COPD Based on GEO Datasets, Network Pharmacology, Molecular Docking, and Molecular Dynamics Simulations

  • Authors: Liyuan Pang; Yongjuan Zhao; Yang Xu; Chencheng Gao; Chao Wang; Xiao Yu; Fang Wang; Kan He
  • Journal: Biology
  • Year: 2024

"Integrated Multi-Omics Analysis Reveals Mountain-Cultivated Ginseng Ameliorates Cold-Stimulated Steroid-Resistant Asthma by Regulating Interactions among Microbiota, Genes, and Metabolites

  • Authors: Daohao Tang; Chao Wang; Hanlin Liu; Junzhe Wu; Luying Tan; Sihan Liu; Haoming Lv; Cuizhu Wang; Fang Wang; Jinping Liu
  • Journal: International Journal of Molecular Sciences
  • Year: 2024

"The Role of Metabolomics and Microbiology in Urinary Tract Infection

  • Authors: Haoyu Zheng; Chao Wang; Xiao Yu; Wenxue Zheng; Yiming An; Jiaqi Zhang; Yuhan Zhang; Guoqiang Wang; Mingran Qi; Hongqiang Lin et al.
  • Journal: International Journal of Molecular Sciences
  • Year: 2024

"PLGA-Based Micro/Nanoparticles: An Overview of Their Applications in Respiratory Diseases

  • Authors: Xiaoping Guo; Xu Zuo; Zhengjie Zhou; Yinuo Gu; Haoyu Zheng; Xinlei Wang; Guoqiang Wang; Caina Xu; Fang Wang
  • Journal: International Journal of Molecular Sciences
  • Year: 2023

Pinelopi Petropoulou | Diabetes | Best Researcher Award

Dr. Pinelopi Petropoulou | Diabetes | Best Researcher Award

University of West Attica | Greece

Author Profile

Scopus

Orcid ID

📚 DR. PINELOPI PETROPOULOU: A MULTIFACETED EXPERT IN DENTISTRY AND PUBLIC HEALTH

📖 EARLY ACADEMIC PURSUITS

Dr. Pinelopi Petropoulou was born and resides in Athens, Greece. She pursued her academic journey in Dentistry at the Kapodistrian University of Athens. Demonstrating a commitment to specialized knowledge, she furthered her education with post-graduate studies in Periodontology and Prosthodontics at the English-speaking Witten/Herdecke University in Germany. Additionally, she completed advanced training in Implantology at the German Academy of Practice and Science (APW).

Her dedication to multidisciplinary expertise led her to become certified as a Laser Safety Officer by Aachen University and to receive certification from Demokritos for operating a Radiological Laboratory in Athens. Moreover, she is currently a Ph.D. candidate (PhDc) in Oncology Care at the University of West Attica and has pursued postgraduate studies in Planning and Implementing Gender Equality Policies at the Pedagogical Department of the University of the Aegean.

💼 PROFESSIONAL ENDEAVORS

Dr. Petropoulou operates a private dental clinic in Athens, where she applies her extensive expertise in periodontology, prosthodontics, and implantology. Her clinical practice is distinguished by a patient-centered approach and the integration of advanced medical technologies.

In addition to her clinical work, Dr. Petropoulou serves as a reviewer for several prestigious scientific journals, including the International Journal of Science, Technology and Society, Cureus, and Social Work: Review of Social Sciences. Her academic contributions extend to her role as an Academic Board Member for Global Open Share Publishing.

🔬 CONTRIBUTIONS AND RESEARCH FOCUS ON DIABETES

Dr. Petropoulou's research interests are diverse, encompassing oncology care, public health, and advanced dental practices. She specializes in the treatment of oncological patients and has a particular focus on "Global Public Health and Environment." Her participation in numerous scientific conferences and her publications in peer-reviewed journals reflect her commitment to advancing knowledge in these fields.

Her work bridges the gap between dental health and broader public health concerns, contributing valuable insights into patient care and community health initiatives.

🌍 IMPACT AND INFLUENCE

Dr. Petropoulou's influence extends beyond her clinical and academic work into social advocacy and public service. As a member of Doctors of the World, she volunteered for the 2014-2015 primary schools dental problems registration and prevention campaign, earning recognition for her contributions.

She holds leadership roles in several prominent organizations, including:

  • Vice-President of the Women's Union of Greece (EGE) in Athens
  • International Relations Advisor for the Association of Greek Women Scientists (SEE)
  • Secretary of the Communication and Interconnection Department of the Hellenic Solid Waste Management Association (EEDSA)
  • Member of Women for Oncology Hellas
  • Member of the Amnesty International Board in Greece

Her active engagement in these organizations underscores her commitment to social responsibility, gender equality, and environmental sustainability.

📊 ACADEMIC CITATIONS

Dr. Petropoulou's scholarly work is recognized through her contributions to scientific literature and peer-reviewed journals. Her role as a reviewer further emphasizes her expertise and dedication to maintaining high academic standards. Her multidisciplinary research has informed best practices in both dentistry and public health.

🏆 LEGACY AND FUTURE CONTRIBUTIONS

Dr. Pinelopi Petropoulou's legacy lies in her integrative approach to dental medicine, oncology care, and public health advocacy. Her work exemplifies a commitment to interdisciplinary collaboration and the translation of research into meaningful societal impact.

Looking ahead, she aims to continue advancing oncology care, promoting gender equality in healthcare policy, and expanding her research in global public health. Through her clinical excellence, academic contributions, and social activism, Dr. Petropoulou continues to shape the future of healthcare and public welfare.

🌟 OTHER NOTABLE ACHIEVEMENTS

  • Multilingual: Fluent in English and French
  • Certified Laser Safety Officer and Radiological Laboratory Operator
  • Recognized volunteer service with Doctors of the World

Dr. Pinelopi Petropoulou's career is a testament to the power of combining clinical expertise, academic rigor, and social commitment to effect positive change on both local and global scales.

NOTABLE PUBLICATIONS📑

"Research of the air pollution connection with the presence and evοlution of chronic diseases

  • Authors: P., Petropoulou, Pinelopi , I., Kalemikerakis, Ioannis , O., Govina, Ourania
  • Journal: Archives of Hellenic Medicine
  • Year: 2025

Kang Yang | Metabolic Disorders | Best Researcher Award

Dr. Kang Yang | Metabolic Disorders | Best Researcher Award

Northern Jiangsu People's Hospital affiliated with Yangzhou University | China

Author Profile

Scopus

Orcid Id

EARLY ACADEMIC PURSUITS 🎓

Kang Yang embarked on his academic journey at Shandong First Medical University, where he pursued a Bachelor of Medicine (BM) in 2017 under the mentorship of Professor Jianhong Qi. His early interest in sports medicine and rehabilitation laid a strong foundation for his future contributions in the field.

Building on this, he further honed his expertise at Yangzhou University, obtaining a Master of Medicine (MM) in 2020 under the guidance of Professor Xianghe Chen. His postgraduate studies deepened his understanding of rehabilitation techniques, patient care, and innovative treatments in sports medicine.

PROFESSIONAL ENDEAVORS 💼

As a rehabilitation physician and therapist, Kang Yang is committed to enhancing the quality of life for patients recovering from injuries, surgeries, and physical impairments. His work integrates advanced rehabilitation methodologies with patient-centered approaches to ensure effective recovery and functional restoration.

Throughout his career, he has actively contributed to both clinical practice and academic research, focusing on rehabilitation strategies tailored for athletes and individuals with musculoskeletal disorders.

CONTRIBUTIONS AND RESEARCH FOCUS ON METABOLIC DISORDERS🔬

Kang Yang’s research primarily revolves around sports medicine and rehabilitation medicine. His investigations explore:

  • Innovative rehabilitation techniques for sports-related injuries.
  • Physiological and biomechanical adaptations in long-distance runners and athletes.
  • Post-injury recovery protocols aimed at optimizing healing and preventing re-injury.

His dedication to research has led to significant advancements in sports rehabilitation, with a particular focus on marathon runners and endurance athletes.

IMPACT AND INFLUENCE 🔍

Kang Yang's contributions extend beyond clinical settings. His work has influenced:

  • Rehabilitation strategies for sports professionals.
  • Medical education, through his involvement in teaching and mentoring young medical students.
  • Public awareness on the importance of injury prevention and rehabilitation in sports.

His clinical expertise and research have helped shape modern rehabilitation protocols, making a positive impact on both patient outcomes and medical practices.

ACADEMIC CITATIONS AND RECOGNITION 🏆

Kang Yang’s academic excellence has been recognized through multiple prestigious awards:

  • Special Prize (2018) & First Prize (2019) at the Jiangsu Sports Graduate Innovation Forum.
  • 2019 National Scholarship for Postgraduates (China).
  • First-class academic scholarship from Yangzhou University.

These accolades highlight his commitment to academic excellence, research innovation, and contributions to the medical community.

LEGACY AND FUTURE CONTRIBUTIONS🏰

Looking ahead, Kang Yang aims to:

  • Expand his research on sports rehabilitation and injury prevention.
  • Develop advanced therapeutic protocols for athletes and individuals recovering from physical trauma.
  • Collaborate with international experts to enhance rehabilitation medicine globally.
  • Continue mentoring students and young professionals in the field of rehabilitation sciences.

His unwavering passion and dedication position him as a future leader in the evolving landscape of sports medicine and rehabilitation.

BEYOND MEDICINE: PERSONAL INTERESTS 📚

Outside of his professional life, Kang Yang enjoys:

  • Long-distance running and marathons, reflecting his deep understanding of sports medicine from both a theoretical and practical perspective.
  • Reading, staying updated with the latest medical advancements and broadening his intellectual horizons.

NOTABLE PUBLICATIONS📑

"Exercise alleviates renal interstitial fibrosis by ameliorating the Sirt1-mediated TGF-β1/Smad3 pathway in T2DM mice

  • Authors: X., Chen, Xianghe , X., Zeng, Xinyu , X., Qiu, Xiao , X., Zhou, Xiangxiang , K., Yang, Kang
  • Journal: Endocrine Connections
  • Year: 2024

Jaina Razbek | Epidemiology | Best Scholar Award

Dr. Jaina Razbek | Epidemiology | Best Scholar Award

Xinjiang Medical University | China

Author Profile

Scopus

Orcid ID

Jaina Razbek, Ph.D. Candidate 🩺📊

Pioneering Research in Tuberculosis Prevention and Genetic Epidemiology

EARLY ACADEMIC PURSUITS 🎓

Jaina Razbek embarked on her academic journey with a strong foundation in public health and epidemiology. She is currently pursuing her doctoral studies at the Department of Epidemiology and Health Statistics, College of Public Health, Xinjiang Medical University. Her early academic training provided her with the skills to analyze disease patterns, conduct large-scale epidemiological studies, and develop statistical models for public health interventions.

PROFESSIONAL ENDEAVORS & RESEARCH PROJECTS 🔬📚

Jaina's research primarily focuses on tuberculosis prevention and control, genetic epidemiology, and health economic evaluations. She has actively contributed to various prestigious research projects, playing critical roles in data organization, statistical analysis, and causal inference modeling.

Notable Research Projects:

🔹 Health Economic Evaluation of Early Screening and Preventive Treatment for Latent Tuberculosis Infection (2023-2025): Investigating cost-effectiveness models for TB prevention strategies.
🔹 Evaluation of Tuberculosis Prevention Models in Southern Xinjiang (2023-2024): Analyzing key intervention factors using cohort and implementation science frameworks.
🔹 Causal Effect Evaluation of the ‘Xinjiang Model’ for TB Prevention (2025-2028): Studying the impact of TB control policies through RE-AIM and stepped-cluster randomized trials.
🔹 Role of Vitamin D in Latent Tuberculosis Infection (2021-2024): Conducting causal inference studies on the effects of vitamin D in TB progression.

CONTRIBUTIONS & RESEARCH FOCUS ON EPIDEMIOLOGY🔍📖

Jaina’s research has significantly contributed to understanding the genetic and epidemiological factors influencing tuberculosis and metabolic diseases. Her studies focus on:

Tuberculosis Prevention & Control – Developing early screening methods and evaluating intervention effectiveness.
Genetic Polymorphisms & Disease Susceptibility – Examining the role of vitamin D receptor gene polymorphisms in TB.
Public Health Strategies – Enhancing disease prevention strategies through statistical modeling and health economics.
Epidemiological Methods & Causal Inference – Applying advanced statistical frameworks to investigate complex disease mechanisms.

IMPACT & INFLUENCE 🌍

Jaina's research has played a vital role in shaping tuberculosis prevention strategies in high-incidence regions like Xinjiang. Her contributions to causal inference in genetic epidemiology have furthered the understanding of gene-disease interactions, helping predict disease susceptibility and treatment responses.

Her involvement in major national and provincial-level research projects underscores her ability to bridge theoretical epidemiology with practical public health solutions.

ACADEMIC CITATIONS & SCHOLARLY OUTPUT 📑

Jaina Razbek has published multiple high-impact research papers in SCI-indexed journals, demonstrating her scholarly excellence. Some of her most notable publications include:

📄 Vitamin D Receptor Gene Polymorphisms Differentiated Between Tuberculosis Disease and Infection – Published in Infection and Drug Resistance (2024).
📄 Association of Serum Levels of TNF-α, IL-10, IFN-γ, and CXCL5 with Latent Tuberculosis – Published in Infection and Drug Resistance (2024).
📄 Causal Association Study of Metabolic Syndrome Development Using Longitudinal Data – Published in Scientific Reports (2024).
📄 Dynamic Progression and Risk Assessment of Metabolic Syndrome Using a Multi-State Markov Model – Published in Diabetes, Metabolic Syndrome, and Obesity (2022).
📄 Xinjiang Metabolic Syndrome Risk Prediction Model Using Interpretable Models – Published in BMC Public Health (2022).

These contributions have earned her widespread recognition, with citations in public health and epidemiology research worldwide.

LEGACY & FUTURE CONTRIBUTIONS 🔮

Jaina Razbek's research has laid the groundwork for improving tuberculosis prevention strategies through genetic and economic evaluations. Moving forward, she aims to:

🌟 Advance the field of epidemiological modeling for infectious diseases.
🌟 Develop precision medicine approaches for tuberculosis based on genetic susceptibility markers.
🌟 Integrate AI-driven analytics into public health decision-making.
🌟 Mentor future epidemiologists and expand global collaborations in disease prevention research.

CONCLUSION 🏆

Jaina Razbek is an emerging leader in epidemiology and public health research, with a deep commitment to disease prevention and health policy optimization. Her innovative research, impactful publications, and dedication to public health continue to shape the future of tuberculosis control and epidemiological science.

NOTABLE PUBLICATIONS📑

"Causal association study of the dynamic development of the metabolic syndrome based on longitudinal data

  • Authors: Razbek, J. , Bao, L. , Zhang, Y. , Daken, M. , Cao, M.
  • Journal: Scientific Reports
  • Year: 2024

"Vitamin D Receptor Gene Polymorphisms Differentiated Between Tuberculosis Disease and Infection: Causal Association Study

  • Authors: Razbek, J. , Chen, Y. , Yang, J. , Aili, A. , Cao, M.
  • Journal: Infection and Drug Resistance
  • Year: 2024

"Association Studies of Serum Levels of TNF-α, IL-10, IFN-γ and CXCL 5 with Latent Tuberculosis Infection in Close Contacts

  • Authors: Razbek, J. , Daken, M. , Chen, Y. , Wang, X. , Cao, M.
  • Journal: Infection and Drug Resistance
  • Year: 2024

"Opening the black box: interpretable machine learning for predictor finding of metabolic syndrome

  • Authors: Zhang, Y. , Zhang, X. , Razbek, J. , Daken, M. , Cao, M
  • Journal:BMC Endocrine Disorders
  • Year: 2022

"Construction of Xinjiang metabolic syndrome risk prediction model based on interpretable models

  • Authors: Zhang, Y. , Razbek, J. , Li, D. , Zhang, X. , Cao, M.
  • Journal: BMC Public Health
  • Year: 2022

Yang Xia | Tissue Engineering | Best Researcher Award

Prof Yang Xia | Tissue Engineering | Best Researcher Award

Nanjing Medical University | China

Author Profile

Scopus

🦷 Prof. Xia Yang: Pioneer in Oral Medicine and Bone Tissue Engineering

🎓 EARLY ACADEMIC PURSUITS

Prof. Xia Yang’s journey into the field of Oral Medicine began with her foundational education at Nanjing Medical University, where she earned a B.Sc. in Oral Medicine in the 1990s. She demonstrated a deep commitment to her discipline by advancing her studies with an M.D. in Oral Medicine and subsequently achieving a Ph.D. in Medicine at the same prestigious institution. These academic accomplishments laid the groundwork for her future endeavors in clinical practice, research, and teaching.

🏥 PROFESSIONAL ENDEAVORS

Prof. Xia Yang currently serves as a Professor and Chief Physician at the Institute of Stomatology, Nanjing Medical University. With decades of experience, she has established herself as a leader in oral restoration, merging clinical expertise with innovative research. Her professional focus lies in oral bone tissue engineering and nanotechnology, where she leads a dedicated team to push the boundaries of oral health solutions.

Her achievements in academia include mentoring emerging professionals, contributing significantly to the development of advanced materials for oral health applications, and integrating cutting-edge nanotechnologies into oral medicine.

🧪 CONTRIBUTIONS AND RESEARCH FOCUS TISSUE ENGINEERING

Prof. Xia Yang’s research interests include:

  • Development of Oral Bone Tissue Engineering Materials: Pioneering the creation of innovative materials to enhance oral bone repair and regeneration.
  • Nanotechnology in Oral Materials: Exploring applications of nanotechnology to improve the performance and longevity of oral restorative materials.
  • Clinical Excellence in Oral Restoration: Advancing techniques and materials that provide long-lasting solutions to oral health challenges.

She has been the Principal Investigator for numerous significant research projects funded by national and provincial foundations, including three by the National Natural Science Foundation of China, two by the Jiangsu Province Natural Science Foundation, and a project from the China Postdoctoral Fund.

🏆 AWARDS AND HONORS

Prof. Xia Yang’s contributions have been recognized with prestigious awards:

  • Second Prize, Jiangsu Province Science and Technology Award (2014): Acknowledging her groundbreaking work in dental science and technology.
  • IADR/Heraeus Travel Award in Dental Materials (2013): Honoring her contributions to advancing dental materials research globally.

🌍 IMPACT AND INFLUENCE

Prof. Yang’s work has significantly influenced the fields of oral medicine and bone tissue engineering. By integrating nanotechnology with oral material development, she has expanded the possibilities for durable, biocompatible dental solutions. Her clinical expertise complements her research, directly impacting patients and contributing to advancements in oral healthcare.

📚 ACADEMIC CITATIONS

Prof. Xia Yang’s scholarly output includes numerous high-impact publications in top-tier journals, reflecting her innovative contributions to oral health and materials science. Her research has garnered widespread recognition and continues to inspire her peers and mentees in the academic community.

🌟 LEGACY AND FUTURE CONTRIBUTIONS

Prof. Yang’s legacy is defined by her relentless pursuit of excellence in oral medicine and her innovative approach to integrating nanotechnology with oral materials. Her commitment to education ensures the next generation of professionals will continue to build on her work.

Looking forward, Prof. Yang aims to expand her research into bio-inspired materials and novel therapeutic approaches, ensuring her contributions will leave a lasting impact on oral healthcare globally.

📑 NOTABLE PUBLICATIONS 

"Antibacterial periodontal ligament stem cells enhance periodontal regeneration and regulate the oral microbiome

  • Authors: You, J. , Zhang, Q. , Qian, L. , Jia, L. , Xia, Y.
  • Journal: Stem Cell Research and Therapy
  • Year: 2024

"Infection-Sensitive SPION/PLGA Scaffolds Promote Periodontal Regeneration via Antibacterial Activity and Macrophage-Phenotype Modulation

  • Authors: Guo, Y. , Shi, Z. , Han, L. , Sun, J. , Xia, Y.
  • Journal: ACS Applied Materials and Interfaces
  • Year: 2024

"Strontium-Containing Piezoelectric Biofilm Promotes Dentin Tissue Regeneration

  • Authors: Li, J. , Zhao, X. , Xia, Y. , Jiang, X. , Yuan, G.
  • Journal: Advanced Materials
  • Year: 2024

"Effects of a Novel Magnetic Nanomaterial on Oral Biofilms

  • Authors: Chen, Y. , Li, Z. , Wei, Y. , Lan, F. , Cheng, L.
  • Journal: International Dental Journal
  • Year: 2024

"Surface demineralized freeze-dried bone allograft followed by reimplantation in a failed mandibular dental implant

  • Authors: Zhang, J. , Wang, J. , You, J. , Zhao, Y. , Xia, Y.
  • Journal: Regenerative Biomaterials
  • Year: 2024

Jun Tian | Movement Disorder | Best Researcher Award

Dr. Jun Tian | Movement Disorder | Best Researcher Award

2nd Affiliated Hospital, Zhejiang University, School of Medicine | China

🧠 JUN TIAN: A PIONEER IN NEUROLOGICAL RESEARCH

EARLY ACADEMIC PURSUITS 📚

Jun Tian began his academic journey at Zhejiang University, one of the leading institutions in China, where he obtained his Bachelor's degree in Clinical Medicine (1999-2004). His passion for neurology led him to pursue further specialization, earning a Master's degree in Neurology (2004-2006) from the same institution. During these formative years, he developed a strong foundation in the study of neurological disorders, setting the stage for his future contributions to the field. His academic pursuits culminated in a Ph.D. in Neurology (2009-2013), where he focused on the molecular and cellular mechanisms behind neurodegenerative diseases, particularly Parkinson’s disease.

PROFESSIONAL ENDEAVORS 👩‍⚕️

Jun Tian's professional career took flight in 2006, when he began working as a Resident in the Department of Geriatrics at the Second Affiliated Hospital, School of Medicine, Zhejiang University. His work during this time exposed him to a wide range of neurological conditions affecting older adults, deepening his clinical expertise. In 2009, he transitioned to a Fellowship position in the Department of Neurology at the same institution. In this role, he gained further clinical experience while also pursuing cutting-edge research in neurological disorders, with a particular focus on movement disorders such as Parkinson’s disease and Huntington’s disease.

CONTRIBUTIONS AND RESEARCH FOCUS ON MOVEMENT DISORDER 🔬

Jun Tian’s research has primarily centered on the mechanisms behind neurodegenerative diseases, particularly Parkinson's disease and Huntington’s disease. His work has explored key issues such as mitochondrial dysfunction in neurons and the role of specific neural pathways in disease progression. He has presented his research at multiple prestigious international conferences, including:

  • 2013 at the 17th International Congress of Parkinson’s Disease and Movement Disorders in Australia, where he presented a guided poster tour on mutant Huntingtin protein’s impact on mitochondrial axonal transport in cultured hippocampal neurons.
  • 2014 at the 4th Asian and Oceanian Parkinson's Disease and Movement Disorders Congress in Thailand, where he discussed the effects of optical stimulation of glutamatergic afferent fibers in neural pathways.

IMPACT AND INFLUENCE 🌍

Jun Tian’s research has made significant contributions to the understanding of how neurodegenerative diseases impair neuronal function. His work on mitochondrial axonal transport has provided new insights into the mechanisms by which diseases like Huntington’s affect neuron health, potentially opening new avenues for therapeutic interventions. In addition to his clinical and research roles, he has been recognized for his academic excellence with the prestigious Gekequan Scholarship from Zhejiang University in 2011. This award reflects the high regard his peers and mentors have for his dedication and talent.

ACADEMIC CITATIONS AND SCHOLARLY IMPACT 🏅

Jun Tian’s research, presented at leading international conferences, has been well-received in the academic community. Although specific details about his publications are limited, his work on Parkinson’s disease and mitochondrial dysfunction has the potential to influence future research in these areas, contributing to the growing body of knowledge on how neurodegenerative diseases can be treated or managed.

LEGACY AND FUTURE CONTRIBUTIONS 🌟

Jun Tian is well on his way to establishing a lasting legacy in the field of neurology, particularly in the study of neurodegenerative diseases. His work has already made significant strides in understanding how neurological disorders affect cellular mechanisms, and future research could lead to breakthroughs in treatment strategies for patients suffering from these debilitating conditions. Looking forward, Jun Tian’s contributions to neurology will likely continue to grow, both through his clinical work and his research efforts. His participation in international forums and collaborations with leading researchers will further enhance his impact in the field, ensuring that his legacy endures for future generations of neurologists and researchers.

NOTABLE PUBLICATIONS 📑

"Alzheimer Disease and Epilepsy: A Mendelian Randomization Study" 

  • Authors: Fang, Y., Si, X., Wang, J., Zhang, B., Pu, J
  • Journal: Neurology
  • Year: 2023

"The clinical characteristics of neuronal intranuclear inclusion disease and its relation with inflammation" 

  • Authors: Yan, Y., Cao, L., Gu, L., Zhang, B., Zhao, G.
  • Journal: Neurological Sciences
  • Year: 2023

"Elevated serum anti-Saccharomyces cerevisiae antibody accompanied by gut mycobiota dysbiosis as a biomarker of diagnosis in patients with de novo Parkinson disease"

  • Authors: Chen, Y., Zhang, L.-Y., Fang, Y., Zhang, B.-R., Pu, J.-L.
  • Journal: European Journal of Neurology
  • Year: 2023

"Cytokine and chemokine map of peripheral specific immune cell subsets in Parkinson’s disease"

  • Authors: Jiang, S.-S., Wang, Y.-L., Xu, Q.-H., Tian, J., Pu, J.-L.
  • Journal: npj Parkinson's Disease
  • Year: 2023

"The longitudinal volumetric and shape changes of subcortical nuclei in Parkinson’s disease"

  • Authors: Yang, W., Bai, X., Guan, X., Pu, J., Tian, J.
  • Journal: Scientific Reports
  • Year: 2024